摘要:
Disclosed are compounds of formulae (I) and (II) and salts, hydrates, or solvates thereof, where R 1 , R 2 , R 3 , R 5 , and R 6 are defined herein, compositions containing these compounds, methods of preparing these compounds, and methods of using these compounds in a variety of applications, such as a surfactant or additive in personal care products.
摘要:
Simple organic structures, organic/inorganic polymers, and other substrates have been made, all of which have at least one pyrrolidone moiety present, and found to exhibit low toxicity, low complement activation features and may be used to reduce protein interactions with drug conjugates while enhancing in vivo residency times for these conjugates when used as an injectable composition; thus these compounds can be used as substitutes for PEG in PEGaylation. Surprisingly, these compounds also exhibit unique intrinsic fluorescence (IF) or non-traditional fluorescence (NTF) properties that currently cannot be explained by traditional photochemistry and fluorescence paradigms are described. These compounds have a variety of applications such as in cellular imaging, gene transfection, bio-diagnostics, biosensing, fluorescence directed surgical resections, drug delivery, forensics, environmental diagnostics, mineral/gemstone characterization, counterfeit goods detection, tracer studies related to liquid/water flow, oil field enhancements and diagnostics, prevention of photo-bleaching, and LED display enhancements and others.
摘要:
The present invention relates to novel amide compounds of Formula (I), and their use as anti-tumoral and pro-apoptotic agents. The invention includes the use of such compounds in medicine, in relation to cancer disease as well as other diseases where an inhibition of HDAC is responsive, and the pharmaceutical composition containing such compounds.
摘要:
The present invention relates to amine functionalized lipophilic compounds and their use in personal care products, particularly those for colored hair.
摘要:
This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
摘要:
The present invention provides compounds having the strucutural formula (I) and methods for the treatment of cancer using compounds of formula (I).
摘要:
A compound of formula (I) wherein R1 is hydrogen or an electron withdrawing group; one of X1 to X4 is a CR2R3 group wherein at least one of R?2 and R3 is C1 to C¿6 aliphatic group, an aromatic group, a heterocyclic group, a basic group or R4CONH wherein R4 is a C¿1? to C6 aliphatic group, an aromatic group or a heterocyclic group and any remaining R?2 or R3¿ is hydrogen; at least one of X1 to X4 is a CHR5 group wherein R5 comprises a hydrogen bond donor or acceptor; the remaining X1 to X4 groups are CH¿2?, O or NR?6¿ wherein R6 is hydrogen, a C¿1? to C6 aliphatic group, an aromatic group or a heterocyclic group; and y is 0 or 1, or a pharmaceutically acceptable salt thereof.